Specifically, our work suggests that studying the role of neurotrophins (such as NRN1), in specific phenotypes with particularly etiological underpinnings (such as early-onset) and their effect on intermediate phenotypes (such as functional neuroimaging data), helps to elucidate the impact of common genetic variability on biological networks underlying mental disorders. This evidence concerns the gene BDNF and psychiatric disorder.